U.S. incidence of thyroid cancer plateaued in 2009

(HealthDay)—From 2009 to 2016, the incidence of thyroid cancer reached a plateau and possibly started to decline, according to a research letter published in the Dec. 24/31 issue of theJournal o

Updated on: December 20,2023

U.S. incidence of thyroid cancer plateaued in 2009

(HealthDay)—From 2009 to 2016, the incidence of thyroid cancer reached a plateau and possibly started to decline, according to a research letter published in the Dec. 24/31 issue of theJournal o

Updated on:December 20,2023

Cancer research: Key function of important leukemia gene demystified

by Nina Grötschl,University of Veterinary Medicine—ViennaCredit: Pixabay/CC0 Public DomainThe oncogene EVI1 causes an aggressive type of leukemia, but its exact function has been a mystery. A re

Updated on: December 18,2023

Cancer research: Key function of important leukemia gene demystified

by Nina Grötschl,University of Veterinary Medicine—ViennaCredit: Pixabay/CC0 Public DomainThe oncogene EVI1 causes an aggressive type of leukemia, but its exact function has been a mystery. A re

Updated on:December 18,2023

Cell therapy could improve bone marrow transplant safety

by Tiare Dunlap,University of California, Los AngelesGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104859UCLA researchers report a step forward in the developme

Updated on: January 10,2024

Cell therapy could improve bone marrow transplant safety

by Tiare Dunlap,University of California, Los AngelesGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104859UCLA researchers report a step forward in the developme

Updated on:January 10,2024

Camrelizumab Plus Nab-Paclitaxel Showcases Antitumor Activity in Platinum-Resistant Urothelial

September 30, 2022Ryan ScottThe combination of camrelizumab and nab-paclitaxel produced encouraging responses in patients with platinum-resistant, unresectable locally advanced or metastatic urothelia

Updated on: October 17,2023

Camrelizumab Plus Nab-Paclitaxel Showcases Antitumor Activity in Platinum-Resistant Urothelial

September 30, 2022Ryan ScottThe combination of camrelizumab and nab-paclitaxel produced encouraging responses in patients with platinum-resistant, unresectable locally advanced or metastatic urothelia

Updated on:October 17,2023

Exploring key regulators of programmed cell death in melanoma and the immune system's response

byBrigham and Women’s HospitalExpression of type I interferon receptors by melanoma cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51496-2A new paperpublish

Updated on: September 10,2024

Exploring key regulators of programmed cell death in melanoma and the immune system's response

byBrigham and Women’s HospitalExpression of type I interferon receptors by melanoma cells. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-51496-2A new paperpublish

Updated on:September 10,2024

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than che

Updated on: October 27,2023

Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size

New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than che

Updated on:October 27,2023

Tracking genes to fight breast cancer

byLeiden UniversityMicroscope image of moving breast cancer cells leaving a track. Koedoot: "We switched of certain proteins and then looked to see if the pathways changed." Credit: Es

Updated on: December 20,2023

Tracking genes to fight breast cancer

byLeiden UniversityMicroscope image of moving breast cancer cells leaving a track. Koedoot: "We switched of certain proteins and then looked to see if the pathways changed." Credit: Es

Updated on:December 20,2023

Fertility preservation measures do not appear to increase the risk of breast cancer recurrence

byKarolinska InstitutetCancer-Specific Survival in the Cohort. FP indicates fertility preservation. Credit:JAMA OncologyDOI: 10.1001/jamaoncol.2022.3677Women with a breast cancer dia

Updated on: December 19,2023

Fertility preservation measures do not appear to increase the risk of breast cancer recurrence

byKarolinska InstitutetCancer-Specific Survival in the Cohort. FP indicates fertility preservation. Credit:JAMA OncologyDOI: 10.1001/jamaoncol.2022.3677Women with a breast cancer dia

Updated on:December 19,2023

Scientists discover mutations in blood stem cells can exacerbate colon cancer

Compared with normal mice (top), colonoscopies detect more, and larger, tumors in the intestines of mice with clonal hematopoiesis (bottom). Credit: © 2023 Feng et al. Originally published inJou

Updated on: November 02,2023

Scientists discover mutations in blood stem cells can exacerbate colon cancer

Compared with normal mice (top), colonoscopies detect more, and larger, tumors in the intestines of mice with clonal hematopoiesis (bottom). Credit: © 2023 Feng et al. Originally published inJou

Updated on:November 02,2023

suggest better use of existing drugs increases cervical cancer survival and reduces recurrence

byUniversity College LondonCredit: Unsplash/CC0 Public DomainThe INTERLACE phase III trial assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could redu

Updated on: October 23,2023

suggest better use of existing drugs increases cervical cancer survival and reduces recurrence

byUniversity College LondonCredit: Unsplash/CC0 Public DomainThe INTERLACE phase III trial assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could redu

Updated on:October 23,2023

Radiation therapy for high-risk, asymptomatic bone metastases may prevent pain and prolong life

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainTreating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations an

Updated on: December 20,2023

Radiation therapy for high-risk, asymptomatic bone metastases may prevent pain and prolong life

byAmerican Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainTreating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and hospitalizations an

Updated on:December 20,2023

Pediatric multicenter study shows targeted therapy for high-risk Hodgkin lymphoma reduces relapse

byEmory UniversityHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0A targeted therapy for children with high-risk Hodgkin l

Updated on: December 21,2023

Pediatric multicenter study shows targeted therapy for high-risk Hodgkin lymphoma reduces relapse

byEmory UniversityHodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0A targeted therapy for children with high-risk Hodgkin l

Updated on:December 21,2023